I have read that cortisone injections have been effective in some cases, is this so?

< Back
You are here:
Print

The use of the cortisone, or any form of steroid injections for Peyronie’s disease, was most commonly used in the 1960s through the early 1980s. Theoretically steroids will reduce scar formation by inhibiting fibroblasts from making the primary components of scar, that being collagen. Unfortunately, all steroids can result in tissue atrophy, with weakening of the tissues, and do appear to result in a destruction of the planes between the bundle of nerves and blood vessels which lie over the Peyronie’s plaque. As a result, should the steroid injection therapy fail, which it does regularly, this may make surgery more complicated and comprise neurovascular function of the penis. The primary concern with steroid injection, as with many of the treatments for Peyronie’s disease, is that virtually all of the studies in the past where not controlled with a placebo arm, they were performed with a limited number of patients whose improvement was only reported subjectively without any measurements documenting reduction of deformity. Although there are physicians around the world who may still be using steroid injection, it is my opinion that this should not be used as there are better and safer alternatives such as, verapamil and interferon, which are currently available.

Previous I have had Peyronie’s disease for 1 year and 10 months and just went through Intron A injections every 2 weeks for 3 months. I have not seen any change. The Peyronie’s specialist wants to do a second wave of injections. If this did not work at all, do you think it is wise to go through a second injection battery?
Next In addition to verapamil, colchicine has also been shown to affect the ability of fibroblasts to make collagen. Have studies ever been done to determine whether or not local colchicine delivered via intralesional injection would have results similar, or better, than that of verapamil? Presumably this could deliver the drug to the site of the plaque, but without the systemic ill effects secondary to ingestion of oral colchicine.
Table of Contents